Navigation Links
Genzyme and Sunway to Collaborate on Gene Therapy Program in China
Date:10/25/2007

National Medal of Technology, the highest honor awarded by the President of the United States for technological innovation. In 2006 and 2007, Genzyme was selected by FORTUNE as one of the "100 Best Companies to Work for" in the United States.

With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.

About Sunway

Sunway Biotech Co. Ltd. is a leading Chinese biopharmaceutical company that develops, manufactures and commercializes biotherapeutics primarily for the Chinese market. With expertise in all aspects of development and commercialization, Sunway is able to serve as a key partner to leading western bio-pharmaceutical looking to China for clinical trials, manufacturing and/or sales. With a population exceeding 1.3 Billion and rapid growth in personal income, China is still a largely untapped pharmaceutical market. Sunway, through its partnership model and extensive network, is capitalizing on this opportunity. Sunway is currently in the process of closing an investment round to support its rapidly growing operations.

This press release contains forward-looking statements, including statements about Genzyme's and Sunway's intention to conduct clinical trials of, and ultimately commercialize HIF-1a in China. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these forward-looking statements. These risks and uncertainties include, among others: Genzyme's and Sunway's ability to transf
'/>"/>

SOURCE Genzyme Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cytochroma settles lawsuit with Genzyme
2. Genzyme sues former Bone Care employees
3. Genzyme acquistion of Bone Care approved, significant impact forecast
4. GE, St. Jude to collaborate on visualization technology
5. GE Healthcare, MobileAccess to collaborate on hospital wireless
6. GE Healthcare, Harvard medical school to collaborate on nervous system research
7. Madison, Milwaukee med schools to collaborate on tech transfer
8. EraGen collaborates with Emory University on HIV detection system
9. The Genesis of Gendicine: The Story Behind the First Gene Therapy
10. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
11. TomoTherapy opens technical training center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015  Thingee Corporation, a software development company for ... entitled, "Technology Adoption: Making Reps, Lives Easier" during the ... Technology ,  in Deerfield Beach, Florida ... Audiences looking to learn how technology can help them ... in the audience for the Thingee presentation. ...
(Date:3/3/2015)... 3, 2015 Kindred Biosciences, Inc. (NASDAQ: ... the lives of pets, announced today that it will release ... 12, 2015 after the market close. The Company will host ... Interested parties may access the call by ... internationally, and using conference ID 98449349.  The ...
(Date:3/3/2015)... March 03, 2015 Cambridge Semantics, the ... Web technology, today announced that it has been named ... Matter in Knowledge Management.’ , To create the ... colleagues, analysts and system integrators who identify organizations dedicated ... the right information to the right people at the ...
(Date:3/3/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/gxqhg9/gene_therapy ) ... report "Gene Therapy - Technologies, Markets and ... Gene therapy technologies are described in detail ... with genetically modified vectors. Gene therapy is an ... of administration as well as targeted gene therapy ...
Breaking Biology Technology:Thingee to present at 11th Annual Synergistix Users Conference 2Cambridge Semantics Named to KMWorld’s 2015 ‘100 Companies That Matter in Knowledge Management’ 2Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 2Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 3
... Provides Unrestricted Educational Grants to Support the 25th Biennial Cornea ... ... Meeting -, TAMPA, Fla., Sept. ... its support of the advancement of ocular innovation through its,contributions of ...
... Representatives from FDA and Leading Pharmaceutical Companies Slated to ... ... Pharsight,Corporation (OTC Bulletin Board: PHST), a leading provider of software and,strategic ... fourth annual Pharsight(R) Knowledgebase,Server(TM) (PKS(TM)) User Group Meeting on October 3 and ...
... Life Sciences, a Roche company, in collaboration with ... developed a method, using the companys Genome Sequencer ... an unprecedented level of detail. The new method ... the gross changes to the genetic code much ...
Cached Biology Technology:Sirion Therapeutics Supports Ophthalmic Education 2Pharsight Hosts Fourth Annual PKS User Group Meeting 2Pharsight Hosts Fourth Annual PKS User Group Meeting 3454 sequencing uncovers significant genetic variation 2
(Date:2/13/2015)... ACT Genomics Co., Ltd., a cancer ... cancer genomic information into precision diagnosis and personalized ... US$ 8 million in the its first private funding ... Taiwan , ACT Genomics has developed comprehensive ... to implement next generation sequencing (NGS) and multiplex ...
(Date:2/10/2015)... 2015  Alere Inc. (NYSE: ALR), a global ... for the quarter ended December 31, 2014. ... of Alere said, "We made substantial progress in ... global leader in rapid diagnostics and delivering against ... divestiture in early January enabled us to substantially ...
(Date:2/5/2015)... 2015   Epic Sciences , a precision diagnostics company ... Murali Prahalad , Ph.D., president and CEO, is scheduled ... (PMWC) 2015: Silicon Valley, which is taking place at the ... on January 26-28, 2015. Dr. Prahalad ... Biomarkers." Last year, Epic Sciences was a finalist in the ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35
... evidence that a direct interaction between vitamin D and ... multiple sclerosis (MS). The research, published on 6 February ... that vitamin D deficiency during pregnancy and the early ... MS later in life. MS is the most ...
... (NYSE: CSC ) announced today that it ... and Support Services Unrestricted contract by the Department of ... (IDIQ) contract covers a broad range of services, solutions ... BTF business and program units. The contract has a ...
... Feb. 3 SectorWatch.biz announces the availability of a commentary ... Controls, Inc. (OTC Bulletin Board: FOUR), Magal Security Systems Ltd. ... NSSC ), Pointer Telocation (Nasdaq: PNTR ... Systems Inc. (NYSE: CKP ).To view the FiSpace.net ...
Cached Biology News:Genetic study shows direct link between vitamin D and MS susceptibility 'gene' 2Genetic study shows direct link between vitamin D and MS susceptibility 'gene' 3CSC Awarded Department of Defense Biometrics Contract 2SectorWatch.biz Issues Commentary for Investors of Homeland Defense Companies FOUR, MAGS, NSSC, PNTR, BCO, and CKP 2
ICAD Purified Anti-Mouse clone Polyclonal, Isotype Rabbit Ig, 200 µl Consult technical datasheet for details....
...
Indoleamine 2,3-dioxygenase [IDO]...
... [F30 P7 D7 F5] to RYK ... applications). Antigen: ... corresponding to amino acids 462 - ... Entrez Gene ID: 6259 ...
Biology Products: